it's the market being down is the problem. It was up nicely at 8.50++ in the AM when XBI was up 1%+. The market dropped further which added pressure to biotechs. most of the other biotech stocks I'm watching dropped from 2.5%+ to the negative territory now but bounced back a bit now.
but i think once the market recovers, we'll have a nice year end rally which also helps biotechs.
News 
Market Data 
Discover 
